Curriculum Vitae

 

Name:

Haideh Darabi (Medical Technology Doctor)

Address:

Immunology Dept., Pasteur Institute of Iran (IPI), No. 69, Pasteur Ave., Tehran 1316943551, Iran

Tel:

(+98-21) 6695 3311-20   ext. 2168

Fax:

 (+98-21) 6696 8857

E- mail:

hdarabi@pasteur.ac.ir  

Nationality:

Iranian

Date of Birth:

9 Nov 1963

Marital Status:

Single

Position:

Research Associate

Education:

bullet

Medical Technology Doctor (1993): Iran University of Medical Science, Tehran , Iran .

bullet

High Diploma in Medical Laboratory Techniques (1986): Iran University of Medical Science, Tehran , Iran .

Supervisor on Student Thesis:

bullet

“Study of T_lymphocyte response to different species of leishmania Ags of recovered patients”, 1998, Medical Technology Doctorate, Iran University of Medical Science .

bullet

 “Quantitative evaluation of IgG,M,A and study of lymphocyte B and T subsets in Downs syndrome patients”, 1994, Medical Technology Doctorate, Shahid Beheshti University .

Professional Experiences:

bullet

Research Associate

bullet

In Pasteur Institute of Iran (1993-present)

Award:

bullet

“Preparation and evaluation of Iranian standard Leishmanin for human skin testing”: Conducted by Dr. Alimohammdian MH. , Kojory ZF. , Darabi H., Malekzadeh SH., 9th Kharazmi International Festival.

 

Teaching Courses:

1 - Teaching of Practical Immunology and Serology, Undergraduate.

2 - Flow cytometry, workshop of  infectious disease.

Technical Skills:

bullet

Cell culture

bullet

ELISA

bullet

Flow cytometry

bullet

Cytokine assay

bullet

RFLP

Language skills: (English)

 

Publications:

  1. Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum. Sima Rafati, Alireza Nakhaee, Tahere Taheri, Yasaman Taslimi, Haideh Darabi, Davood Iravani, Stephanie Sanos, Paul Kaye, Mahammad Taghikhani, Shahram Jamshidi, Mohammad Ali Rad. Vaccine 2005, 23: 3716-25.

  2. Partial purification of a potent immunosuppressive factor excreted from Leishmania major promastigotes. Mohsen Abolhassani, Haideh Darabi. Iranian Biomedical Journal, April 2004, 8(2) 95-99.

  3. “Expansion of  γδ T cells in patients infected with cutaneous leishmaniasis with or without Glucantime therapy”: Darabi H., Kariminia A., Abolhassani M., Alimohammadian MH., 2002, The Brazilian Journal of Infections Diseases, 6(5): 258-262.

  4. Adjuvant effect of Leishmania major promastigotes on the immune response of mice to ovalbumin. Mohammad Hossein Alimohammadian, Haideh Darabi, Amina Kariminia, Denis Rivier, Philipe Bovary, Jacques Mauel, Sohaila Ajdary, and Arsalan Kharazmi. Iranian Biomedical Journal, 2002, 6(4): 123-8.

  5. “The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leismaniasis”: Alimohammadian MH., Khamesipour A., Darabi H., Firooz F., Malekzadeh Sh., Bahonar A., Dowlati Y., Modabber F., 2002,  Vaccine, 21: 174-180.

  6. “Induction of Th1 response is more potent by live logarithmic phase promastigotes of L. major than stationary phase parasites”: Kariminia A., Darabi H., Keyhani AH. and Alimohammadian MH., Jan. 2001, Iranian Biomedical Journal.

  7. “Compositional changes of PBL population in patients with chronic Hepatitis B virus infection”: Khabiri Ar., Abolhassani M., Aslanian S., Darabi H., Bageri F., Alimohammadian MH., 2001, The Brazilian Journal of Infection Diseases, 5(6): 345-351.

  8. “Partially induced protection by a fraction of Leishmania major promastigotes against Murine Leishmaniasis”: Malekzadeh Sh.,Hoseini MH., Darabi H., Alimohammadian MH., 1998, Iranian Biomedical Journal, 2(1): 27-32.

  9. “Soluble Leishmania as an ideal reagent for skin testing in human Leishmaniasis”: Alimohammadian MH., Kojori ZF., Darabi H., Malekzadeh Sh., Yousef-Beig M., Iravani-nia F., 1997, Iranian Biomedical Journal, 1 (1): 39-47.

  10. “Study of CMI in pulmonary tuberculosis and it’s changes 2 months after selective treatment”: Salekmoghaddam AR. and Darabi H., 1996, Journal of Medical Council of Islamic Republic of Iran,14 (1/2): 58-66.

 

International Conference presentations:

  1. “Isolation of a Leishmania major protein capable of induction delayed-type hypersensitivity reaction and Th1 responses”: Alimohammadian M.H., Khabiri A.R., Bagheri F., Kariminia A., Darabi H., 7-9 May 2002,  6th Iranian Congress of Immunology and Allergy, Tehran, Iran.

  2. “Immunosuppression induced by Leishmania major excretory factor:The effect of heat shock”: Kariminia  A., Ardestani  SK., Darabi H., 20-24 May 2001,World  Leish II., Crete, Greece.

  3. “Inhibitory activity of Leishmania major culture supernatant on lymphocyte of BALB/c mice”: Abolhassani M., Darabi H., 20-24 May 2001, World Leish II., Crete, Greece.

  4. “Expansion of γδ  T cells in human cutaneous leishmaniasis”: Darabi H., Karaminia A., Abolhassani M., Alimohammadian MH. , 20-24 May  2001, World Leish II., Crete, Greece.

  5. “The role of BCG in immune responses induced by multiple doses of autoclaved Leishmania major vaccine injection”: Alimohammadian MH. , Khamessipour A., Sacks D., Darabi H., 20-24 May  2001, World Leish II., Crete, Greece.

  6. “Procyclic promastigotes of L. major confere more efficeint immunity than metacyclic one in Balb/c mice”: Alimohammadian MH. , Malekzadeh SH., Kariminia A., Darabi H., 20-24 May  2001, World Leish II., Crete, Greece.

  7. “Immune responses of healthy volunteers to multiple injections of an autoclaved L. major vaccine plus BCG”: Alimohammadia MH. , Khamessipour A. , Sacks D. , Darabi H. , Dowlati Y, Jan. 2000, 2nd FIMSA  Congress Immunology and Allergy, Bangkok , Thailand.

  8. “Study of IL-10 and IL-12 induction in CD14+ cells isolated from healthy individuals in response to L. major antigen using flow cytometry”:Kariminia A., Ardestani SK., Darabi H. Jan 2000,  8th Iranian Congress on Infectious Disease and Tropical Medicine, Tehran, Iran.

  9. “Study of immune system in children with Down’s syndrome” Darabi H., Asslanian S., Kariminia A., 17-19 May 2000,  5th Iranian Congress of Immunology and Allergy, Tehran , Iran.

  10. “Antiproliferation effect of Tucrium polium on human lymphocyte”: Jamali H., Vodjgani M., Darabi H., 17-19 May 2000,5th Iranian Congress of Immunology and Allergy, Tehran, Iran.

  11. “Effect of teucrium polium crude infusion on lymphocyte proliferation”: Jamali H., Vodjgani M., Darabi H., 16-20 May 1999,14th Congress of Physiology and Pharmacology, Tehran , Iran.

  12. “Induction of Th1 response by L. major promastigotes when used as adjuvant”: Alimohammadian MH., Darabi H., Kariminia A., Ajdari S., Modabber F., Nov. 1998, 10th International Congress of Immunology, New Delhi, India.

  13. “The role of T-cell phenotypes and their secreted cytokines in Cutaneous leishmaniasis”:Alimohammadian M.H., Darabi H., Malekzadeh Sh., M.Niknam M., Bahonar A., Afzali H.,  1998, The 4th International Congress of Immunology, Isfahan, Iran.

  14. “Immune system study of children having severe side effect following BCG inoculation”: Arshi S., Farhoody AH. , Sepahzad T., Darabi H., 1998, The 4th International Congress of Immunology, Isfahan , Iran .

  15. “The effect of Glucantime of T cell fucntion and response to different antigens of Lesihmania species in recovered cases”:Alimohammadian MH. , Vaheed MZ. , Darabi H., 1998, 7th Congress on Infectious Disease and Tropical Meidcine, Babolsar , Iran.

  16. “T-cells phenotypes & cytokine profile in cases cured and patients with active Leishmania major infection”:  Alimohammadian MH., Darabi H., Malekzadeh Sh., Aslaniyan S., 1997,  Journees Scientifiques du reseau International des Institus Pasteur et Institus Associes, Paris, France.

  17. “Expansion of specific CD4+ T cells, producing IFN gamma, by stimulated PBMCs of cured and patients with L. major infection”: Alimohammadian MH, Darabi H., Asslanian S., 1997, 1st world Congress on Leishmaniasis, Istanbul, Turkey.

  18. “Selection of a reference reagent for skin testing in human Leishmaniasis”: Alimohammadian MH., Yousefbaig M., Darabi H., Iravani F.,  Nov. 1996, XIV International Congress of Tropical Medicine and Malaria, Nagasaki, Japan.

 

Back to Member Page                          Back to Immunology Home Page                              Back to Pasteur Institute Home Page